IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
Metastatic melanoma remains a refractory disease. Great progress in therapy of metastatic melanoma patients has been made in the recent five years. Targeted immunotherapy – a selective effect on lymphocytes signal molecules - became a principally new trend in the drug therapy of tumors. Ipilimumab i...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Russo |
| Gepubliceerd in: |
Remedium Group LLC
2016-12-01
|
| Reeks: | Медицинский совет |
| Onderwerpen: | |
| Online toegang: | https://www.med-sovet.pro/jour/article/view/1409 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|